ATE319482T1 - Methode zur herstellung einer lösung aus radioaktiven rheniumkomplexen - Google Patents

Methode zur herstellung einer lösung aus radioaktiven rheniumkomplexen

Info

Publication number
ATE319482T1
ATE319482T1 AT91915046T AT91915046T ATE319482T1 AT E319482 T1 ATE319482 T1 AT E319482T1 AT 91915046 T AT91915046 T AT 91915046T AT 91915046 T AT91915046 T AT 91915046T AT E319482 T1 ATE319482 T1 AT E319482T1
Authority
AT
Austria
Prior art keywords
solution
preparing
radioactive rhenium
radioactive
rhenium complexes
Prior art date
Application number
AT91915046T
Other languages
English (en)
Inventor
Helena Panek-Finda
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Application granted granted Critical
Publication of ATE319482T1 publication Critical patent/ATE319482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT91915046T 1990-07-06 1991-07-02 Methode zur herstellung einer lösung aus radioaktiven rheniumkomplexen ATE319482T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90201817 1990-07-06

Publications (1)

Publication Number Publication Date
ATE319482T1 true ATE319482T1 (de) 2006-03-15

Family

ID=8205061

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915046T ATE319482T1 (de) 1990-07-06 1991-07-02 Methode zur herstellung einer lösung aus radioaktiven rheniumkomplexen

Country Status (11)

Country Link
EP (1) EP0538402B1 (de)
JP (1) JP3370666B2 (de)
AT (1) ATE319482T1 (de)
AU (1) AU654967B2 (de)
CA (1) CA2086244C (de)
DE (1) DE69133514T2 (de)
DK (1) DK0538402T3 (de)
ES (1) ES2255046T3 (de)
GR (1) GR990300021T1 (de)
IL (1) IL98750A (de)
WO (1) WO1992000758A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7312694A (en) * 1994-06-03 1996-01-04 Mallinckrodt Medical, Inc. Rapidly clearing technetium-99m phosphonate skeletal imaging agents
EP1356827A1 (de) 2002-04-24 2003-10-29 Mallinckrodt Inc. Verfahren zur Herstellung von einer 2-18F-Fluor-2-Deoxy-D-Glucose (18F-FDG)-Lösung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935222A (en) * 1986-06-13 1990-06-19 University Of Cincinnati Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit
EP0300431A3 (de) * 1987-07-22 1990-06-27 Neorx Corporation Methode zur Bindung von radionukliden Anschwefel enthaltende Chelate
DE3862077D1 (de) * 1987-07-23 1991-04-25 Id Handel Gliederradiator.
US4839467A (en) * 1988-06-15 1989-06-13 University Of Cincinnati Radioactive rhenium complexed to 2-hydroxy isobutyric acid
US4925925A (en) * 1988-06-15 1990-05-15 University Of Cincinnati Radioactive rhenium ligated to 2-hydroxy isobutyric acid and method of use
FR2636632B1 (fr) * 1988-09-16 1996-02-02 Oris Ind Produits radiopharmaceutiques constitues par des complexes de tc, re ou y comportant des ligands tetraphosphonates et leur preparation
US5021235A (en) * 1989-05-02 1991-06-04 Mallinckrodt, Inc. Preparation of rhenium phosphonate therapeutic agents for bone cancer without purification

Also Published As

Publication number Publication date
IL98750A (en) 1996-10-16
EP0538402B1 (de) 2006-03-08
JPH05509324A (ja) 1993-12-22
WO1992000758A1 (en) 1992-01-23
JP3370666B2 (ja) 2003-01-27
CA2086244A1 (en) 1992-01-07
EP0538402A4 (en) 1994-07-27
IL98750A0 (en) 1992-07-15
DE69133514T2 (de) 2006-09-28
AU654967B2 (en) 1994-12-01
GR990300021T1 (en) 1999-07-30
AU8433691A (en) 1992-02-04
CA2086244C (en) 2001-10-16
EP0538402A1 (de) 1993-04-28
ES2255046T3 (es) 2006-06-16
DK0538402T3 (da) 2006-07-10
DE69133514D1 (de) 2006-05-04

Similar Documents

Publication Publication Date Title
DE69109746D1 (de) Verfahren zur Herstellung von Acrolein oder Methacrolein.
CH684514GA3 (de) Verfahren zur Herstellung von wässrigen Dispersionen von oxydierten Schwefelfarbstoffen.
ATE24480T1 (de) Verfahren zur herstellung von quartaeren ammoniumverbindungen.
ATE20735T1 (de) Verfahren zur herstellung von 2-cyanacrylaten aus 2,4-dicyanglutaraten.
ATE69177T1 (de) Verfahren zur rueckgewinnung von rhodium aus rhodiumkomplex-verbindungen enthaltenden waessrigen loesungen.
ATE319482T1 (de) Methode zur herstellung einer lösung aus radioaktiven rheniumkomplexen
ATE11131T1 (de) Verfahren zur herstellung von oelloeslichen metallsalzen.
DE3854245D1 (de) Verfahren zur Herstellung von Chinolinen.
DE59102161D1 (de) Verfahren zur Herstellung von 3-Methylpyrazol.
BR9103660A (pt) Processo para o aperfeicoamento de resistencia a corrosao de componentes nitrocarburados de materiais ferrosos
ATE124268T1 (de) Verfahren zur herstellung von therapeutischen rhenium-phosphonat-mitteln.
ATE98952T1 (de) Verfahren zur herstellung von benzaldehyden.
ATE76868T1 (de) Verfahren zur herstellung von 1,2-disulfonverbindungen.
DE3678487D1 (de) Verfahren zur herstellung von 6-amino-3-hydrazino-pyridazinderivaten.
DE3682816D1 (de) Verfahren zur herstellung von 2-carboxypyrazin-4-oxiden.
ATE1239T1 (de) Verfahren zur herstellung von 4-amino-5-chlor-1-phenyl-pyridazon-(6).
ATE61059T1 (de) Verfahren zur herstellung von vincristin.
DE59809481D1 (de) Verfahren zur Herstellung von Aminocyanacetamid
ATA405879A (de) Verfarhren zur herstellung neuer 2,3,5,8-tetrahydrofuro- bzw. 5,8-dihydrofuro-1,8-naphthyridine-verbindung
DE69112236D1 (de) Verfahren zur mikrobiologischen Herstellung von Ironen.
ATE113269T1 (de) Verfahren zur herstellung von ungesättigten bromiden.
DE3750605D1 (de) Verfahren zur Herstellung von N,N-disubstituierten Beta-Aminopropionsäuren und ihre Verwendung zur Hydrophobierung von Leder und Pelzen.
ATE9477T1 (de) Verfahren zur herstellung von 1,1'-diacetalen.
ATE10936T1 (de) Verfahren zur herstellung von 2-alkoxy-4aminopyrimidinen.
ATE272T1 (de) Verfahren zur herstellung von bis-2-pyridyl-disulfiden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0538402

Country of ref document: EP

REN Ceased due to non-payment of the annual fee